Active Startup: ANANDA

Published: 10 October 2019

Business Snapshot
The company manufactures microfluidic platforms for the diagnostics and biomedical research markets. The technology increases the standardization, precision and reproducibility of cell assays and can be integrated with sensors and electronic devices in order to acquire, store and manage data at a single cell level.

Target Markets
Diagnostics and biomedical research markets

Intellectual Property
In prosecution.

Margaret Magdesian

Back to top